Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells
- PMID: 16170693
- DOI: 10.1007/s11095-005-8175-y
Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells
Abstract
Purpose: The effect of chitosan and polyethylene glycol (PEG)ylated trimethyl chitosan copolymer structure on the uptake and transport of insulin nanocomplexes was evaluated and transport mechanisms were investigated.
Methods: Insulin nanocomplexes were prepared from chitosan and its copolymers by self-assembly. Complex uptake in Caco-2 cells was quantified by measuring the cell-associated fluorescence and cellular localization was visualized by confocal laser scanning microscopy (CLSM) using tetra-methyl-rhodamine isothiocyanate-labeled insulin. The transport of selected insulin complexes through Caco-2 monolayers was then investigated and compared with in vivo uptake by nasal epithelium in diabetic rats.
Results: All complexes were 200-400 nm in diameter, positively charged, and displayed an insulin loading efficiency of approximately 90%. In vitro release of insulin from the complexes was dependent on the medium pH. Insulin uptake was enhanced by nanocomplex formation, and was dependent on incubation time, temperature, and concentration. Complex uptake in Caco-2 cells was inhibited by 25.2 +/- 1.3%, 13.0 +/- 1.0%, and 16.6 +/- 0.7% in the presence of cytochalasin D, sodium azide, and 2,4-dinitrophenol, respectively. The uptake mechanism was assumed to be adsorptive endocytosis. Additionally, cell uptake efficiency was shown to be influenced by a combination of polymer molecular weight, viscosity, and positive charge density. However, none of the nanocomplexes displayed improved transport properties when compared to insulin transport data after 2 h incubation with Caco-2 monolayers. This result was further confirmed with animal experiments.
Conclusions: Small, stable insulin nanocomplexes were formed using PEGylated trimethyl chitosan copolymers, which significantly enhanced the uptake of insulin in Caco-2 cells by adsorptive endocytosis. However, nanocomplexation did not seem to enhance transcellular insulin transport across cell monolayers, which is in line with animal data in rats. This implies that PEGylated trimethyl chitosan complexes with insulin need further optimization and the Caco-2 cell line is a predictable in vitro cell culture model for drug absorption.
Similar articles
-
The role of mucoadhesion of trimethyl chitosan and PEGylated trimethyl chitosan nanocomplexes in insulin uptake.J Pharm Sci. 2009 Dec;98(12):4818-30. doi: 10.1002/jps.21783. J Pharm Sci. 2009. PMID: 19408295
-
Uptake, transport and peroral absorption of fatty glyceride grafted chitosan copolymer-enoxaparin nanocomplexes: influence of glyceride chain length.Acta Biomater. 2014 Aug;10(8):3675-85. doi: 10.1016/j.actbio.2014.05.003. Epub 2014 May 9. Acta Biomater. 2014. PMID: 24814881
-
Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats.J Pharm Pharmacol. 2010 May;62(5):583-91. doi: 10.1211/jpp.62.05.0004. J Pharm Pharmacol. 2010. PMID: 20609059
-
Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.Eur J Pharm Biopharm. 2004 Sep;58(2):225-35. doi: 10.1016/j.ejpb.2004.03.023. Eur J Pharm Biopharm. 2004. PMID: 15296951 Review.
-
Chitosan and its use in design of insulin delivery system.Recent Pat Drug Deliv Formul. 2009 Jan;3(1):8-25. doi: 10.2174/187221109787158346. Recent Pat Drug Deliv Formul. 2009. PMID: 19149726 Review.
Cited by
-
Nanotechnology: intelligent design to treat complex disease.Pharm Res. 2006 Jul;23(7):1417-50. doi: 10.1007/s11095-006-0284-8. Epub 2006 Jun 21. Pharm Res. 2006. PMID: 16779701 Review.
-
Low molecular weight chitosan-insulin polyelectrolyte complex: characterization and stability studies.Mar Drugs. 2015 Mar 30;13(4):1765-84. doi: 10.3390/md13041765. Mar Drugs. 2015. PMID: 25830681 Free PMC article.
-
Alginate/chitosan nanoparticles are effective for oral insulin delivery.Pharm Res. 2007 Dec;24(12):2198-206. doi: 10.1007/s11095-007-9367-4. Epub 2007 Jun 19. Pharm Res. 2007. PMID: 17577641
-
In vitro cellular localization and efficient accumulation of fluorescently tagged biomaterials from monodispersed chitosan nanoparticles for elucidation of controlled release pathways for drug delivery systems.Int J Nanomedicine. 2018 Sep 5;13:5075-5095. doi: 10.2147/IJN.S164843. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30233174 Free PMC article.
-
Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan.AAPS PharmSciTech. 2011 Dec;12(4):1407-19. doi: 10.1208/s12249-011-9716-9. Epub 2011 Oct 27. AAPS PharmSciTech. 2011. PMID: 22033812 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical